Combined oral contraception and the risk of venous thromboembolism.

By Mills A  

Human Reproduction, Vol. 12, Iss. 12, 1997-12 ,pp. : 2595-2598

Oxford University Press

Access to resources Recommend Favorite

Venous Thromboembolism and Oral Contraceptives: Current Status and Clinical Implications

By Burkman R.T.  

Treatments in Endocrinology, Vol. 1, Iss. 3, 2002-03 ,pp. : 143-147

Adis International

Access to resources Recommend Favorite

Contraception. The differential risk of oral contraceptives: the impact of full exposure history *

By Lewis Michael A.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1493-1499

Oxford University Press

Access to resources Recommend Favorite

Contraception. Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database

By Todd J.-C.   Lawrenson R.   Farmer R.D.T.   Williams T.J.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1500-1505

Oxford University Press

Access to resources Recommend Favorite

Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism

By Tripodi Armando   Legnani Cristina   Lemma Laura   Cosmi Benilde   Palareti Gualtiero   Chantarangkul Veena   Mannucci Pier  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 2, 2010-08 ,pp. : 215-219

Springer Publishing Company

Access to resources Recommend Favorite